Côte d’Ivoire
Côte d’Ivoire
Before PEPFAR’s 2022 country operational plan, ICAP’s approach in Côte d’Ivoire was to improve HIV prevention, care, and treatment, focusing on high-impact strategies such as targeted HIV testing, including index testing and differentiated service delivery models, with innovative capacity-building approaches in laboratory and pharmacy support, quality improvement, and monitoring and evaluation to ensure long-term sustainability and epidemic control. Since 2016, ICAP has also been working with the Ministry of Health to conduct an HIV population-based survey to assess the impact of Côte d’Ivoire’s national HIV response and guide future efforts. ICAP is currently concentrating on supporting the National HIV Program (PNLS) through ICAP’s HIV Learning Network, CQUIN, and Global Fund technical assistance to implement differentiated services along the HIV cascade.
Projects
Long-Term Technical Service Providers of The Global Fund HIV Differentiated Service Delivery Strategic Initiative
- current
Population-based HIV Impact Assessment (PHIA)
- Multi-Country,
- current:
- Cameroon ,
- Cote d’ Ivoire ,
- Democratic Republic of the Congo ,
- Eswatini ,
- Lesotho ,
- Malawi ,
- Tanzania ,
- Uganda
Reaching Impact, Saturation and Epidemic Control (RISE)
- Multi-Country,
- current
The CQUIN Project for Differentiated Service Delivery
- Multi-Country,
- current
ICAP in Côte d’Ivoire
Active Years
- 2007 to present
Key Technical Areas
- COVID-19
- HIV
- Malaria
- Maternal and Child Health
- Non-Communicable Diseases
- Tuberculosis
- Human Resources for Health
- Infection, Prevention, and Control
- Strengthening Health Systems
- Laboratory Strengthening
- Quality Improvement
- Research
- Surveys
- Technical Assistance
Current Funders
- Global Fund
Country Director
Stéphania Koblavi, PharmD, PhD
Dr. Stéphania Koblavi is ICAP’s country director in the Democratic Republic of Congo and the interim country director for ICAP in Côte d’Ivoire. She has over 25 years of experience as a laboratory specialist and expertise in quality improvement through laboratory accreditation preparedness, laboratory training and quality management, laboratory network development, laboratory policy, and strategic planning. She joined ICAP in 2006, working in Rwanda, and in 2010, she supported the start-up of ICAP programs in the Democratic Republic of Congo. In Côte d’Ivoire, she was the strategic and planning director, overseeing and coordinating the development of program planning, monitoring, and reporting systems. Prior to joining ICAP, Stéphania worked with the CDC in Abidjan in the bioclinical laboratory, where she helped establish the rapid testing algorithm for HIV diagnosis. She was then appointed medical research scientist in the immunovirology laboratory, where she explored the specific immune system response to HIV 1 and 2. Dr. Koblavi holds a Doctor of Pharmacy degree from Côte d’Ivoire University and a PhD in microbiology from Institut Pasteur at Université Denis Diderot (Paris VII).
Jobs in Côte d’Ivoire
See the ICAP careers page to search all job listings.
